AngioDynamics to Participate in the 5th Annual Craig-Hallum Institutional Investor Conference
AngioDynamics to Participate in the 5th Annual Craig-Hallum Institutional Investor Conference
QUEENSBURY, N.Y.--(BUSINESS WIRE)--May 19, 2008--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the 5th Annual Craig-Hallum Institutional Investor Conference in Minneapolis on Tuesday, May 20, 2008. AngioDynamics' management will present a review of the Company's business strategy and historical financial results at 8:00 a.m. Central time. Attendance at the conference is by invitation only.About AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons, and other physicians for the minimally invasive treatment of cancer and peripheral vascular disease. The Company's diverse product line includes market-leading radiofrequency ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.angiodynamics.com.
CONTACT: AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
EVC Group, Inc.
Doug Sherk, 415-896-6820 (Investor Relations)
dsherk@evcgroup.com
Donald Takaya, 415-896-6820 (Investor Relations)
dtakaya@evcgroup.com
Chris Gale, 646-201-5431 (Media)
cgale@evcgroup.com
SOURCE: AngioDynamics, Inc.